Clinical Trial Update: Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating hypofractionated radiotherapy for limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Lung Neoplasm, Small Cell Carcinoma | Phase 2 | Status: COMPLETED